Fbxl10 overexpression in murine hematopoietic stem cells induces leukemia involving metabolic activation and upregulation of Nsg2
Takeshi Ueda(Kindai University), Hiroaki Honda(Tokyo Women's Medical University), Akiko Nagamachi(Hiroshima University), Norimasa Yamasaki(Hiroshima University), Toshiya Inaba(Hiroshima University), Atsushi Iwama(Chiba University), Keiyo Takubo(Keio University), Toshio Suda(Chinese Academy of Sciences), Kenichiro Ikeda(Hiroshima University), Hirotaka Matsui(Hiroshima University), Akinori Kanai(Frontier Medical College), Linda Wolff(National Institutes of Health), Takaaki Konuma(University of Tokyo Hospital), Zen‐ichiro Honda(Ochanomizu University), Yuichiro Nakata(University of Miami), Xudong Wu(Tianjin Medical University General Hospital), Hideaki Oda(Hakodate Central General Hospital), Kristian Helin(University of Copenhagen)
Cited by 82
Related Papers
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
|The Lancet|2020|29.1k
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
|Proceedings of the National Academy of Sciences|1998|4.3k
Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis<i>in Vitro</i><sup>1</sup>
|Endocrinology|1998|1.2k
Role of TET enzymes in DNA methylation, development, and cancer
|Genes & Development|2016|1k
DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells
|The Journal of Experimental Medicine|2005|899